Volume 3, Issue 1 (16 2004)
ijdld 2004, 3(1): 35-40 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shamsi B, Hashemipour M, Saadat S H, Emami S M H, Abdyazdan Z, Hasanzadeh A, et al . PREVALENCE OF HELICOBACTER PYLORI INFECTION IN TYPE 1 DIABETIC CHILDREN REFERRING TO ISFAHAN ENDOCRINE & METABOLISM RESEARCH CENTER. ijdld 2004; 3 (1) :35-40
URL: http://ijdld.tums.ac.ir/article-1-453-en.html
URL: http://ijdld.tums.ac.ir/article-1-453-en.html
Behzad Shamsi 
, Mahin Hashemipour * , Sayed Hossein Saadat , Sayed Mohammad Hasan Emami , Zahra Abdyazdan , Akbar Hasanzadeh , Khosrow Khaibi , Sasan Haghighi , Silva Hovsepian
, Mahin Hashemipour * , Sayed Hossein Saadat , Sayed Mohammad Hasan Emami , Zahra Abdyazdan , Akbar Hasanzadeh , Khosrow Khaibi , Sasan Haghighi , Silva Hovsepian
Abstract: (9860 Views)
Increased prevalence of Helicobacter Pylori (HP) infection is a common feature in diabetics, which is attributable to the presence of diverse predisposing factors. In this study, the prevalence of HP infection has been investigated in type 1 diabetic children.
Methods: In a cross-sectional study, anti-HP antibody (IgG) was measured in 75 type 1 diabetics (aged 2-18 years) and the results were compared with 75 healthy children who were matched for age, sex and socio-economic status. In seropositive diabetic patients with gastrointestinal (GI) symptoms, gastroduodenoscopy was performed to establish the diagnosis.
Results: Sera were positive for anti-HP in 22.7% of diabetics versus 17.3% in controls (P>0.05). No significant difference was observable between seropositive and seronegative diabetic groups as regard to age, sex, age at onset of diabetes, number of outpatient visits during the last 6 months, HbAlc and insulin requirements. Gastrointestinal symptoms were more common in diabetics than the healthy controls the prevalence of these symptoms, however, did not differ significantly between seropositive and seronegative diabetics.
Conclusion: The study indicated that type 1 diabetes is not associated with increased risk of HP infection. Further studies are required to investigate the impact of HP infection treatment on the glycemic control in diabetic children.
Methods: In a cross-sectional study, anti-HP antibody (IgG) was measured in 75 type 1 diabetics (aged 2-18 years) and the results were compared with 75 healthy children who were matched for age, sex and socio-economic status. In seropositive diabetic patients with gastrointestinal (GI) symptoms, gastroduodenoscopy was performed to establish the diagnosis.
Results: Sera were positive for anti-HP in 22.7% of diabetics versus 17.3% in controls (P>0.05). No significant difference was observable between seropositive and seronegative diabetic groups as regard to age, sex, age at onset of diabetes, number of outpatient visits during the last 6 months, HbAlc and insulin requirements. Gastrointestinal symptoms were more common in diabetics than the healthy controls the prevalence of these symptoms, however, did not differ significantly between seropositive and seronegative diabetics.
Conclusion: The study indicated that type 1 diabetes is not associated with increased risk of HP infection. Further studies are required to investigate the impact of HP infection treatment on the glycemic control in diabetic children.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
